Lactate/albumin ratio predicts mortality in critically ill COVID-19 patients: a retrospective machine learning study

C Chaofan Liang X Xinyan Zhang (Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston) Q Qingqing Zhu J Jianan Guo Y Yongjun Wu Z Ziqi Wang (Division of Advanced Materials) X Xiaoju Zhang (Department of Respiratory and Critical Care Medicine, Henan Provincial People’s Hospital, University People’s Hospital) Y Yi Kang

Article Details

Volume / Issue Vol. 15, Issue 1
Published October 17, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (8)

C

Chaofan Liang

X

Xinyan Zhang

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, Boston

Q

Qingqing Zhu

J

Jianan Guo

Y

Yongjun Wu

Z

Ziqi Wang

Division of Advanced Materials

X

Xiaoju Zhang

Department of Respiratory and Critical Care Medicine, Henan Provincial People’s Hospital, University People’s Hospital

Y

Yi Kang